George Clinical's Managing Director discusses the concern biopharma companies have with CFDA's slow drug and medical device approvals.
Philip Gregory
Advertisement
Articles by Philip Gregory
Advertisement
Latest Updated Articles
Regulatory Changes Position China as a Global Clinical Trial DestinationPublished: September 11th 2017 | Updated:
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
